These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 11053207)
1. Non-competitive pharmacological antagonism at the rabbit B(1) receptor. Larrivée JF; Gera L; Houle S; Bouthillier J; Bachvarov DR; Stewart JM; Marceau F Br J Pharmacol; 2000 Nov; 131(5):885-92. PubMed ID: 11053207 [TBL] [Abstract][Full Text] [Related]
2. Endogenous aminopeptidase N decreases the potency of peptide agonists and antagonists of the kinin B1 receptors in the rabbit aorta. Fortin JP; Gera L; Bouthillier J; Stewart JM; Adam A; Marceau F J Pharmacol Exp Ther; 2005 Sep; 314(3):1169-76. PubMed ID: 15919764 [TBL] [Abstract][Full Text] [Related]
3. Discovery of a dual-function peptide that combines aminopeptidase N inhibition and kinin B1 receptor antagonism. Gera L; Fortin JP; Adam A; Stewart JM; Marceau F J Pharmacol Exp Ther; 2006 Apr; 317(1):300-8. PubMed ID: 16368899 [TBL] [Abstract][Full Text] [Related]
4. Characterization of bradykinin receptors in a human osteoblastic cell line. Brechter AB; Lerner UH Regul Pept; 2002 Jan; 103(1):39-51. PubMed ID: 11738247 [TBL] [Abstract][Full Text] [Related]
5. Vascular mode of action of kinin B1 receptors and development of a cellular model for the investigation of these receptors. Levesque L; Drapeau G; Grose JH; Rioux F; Marceau F Br J Pharmacol; 1993 Aug; 109(4):1254-62. PubMed ID: 8104648 [TBL] [Abstract][Full Text] [Related]
6. B-9972 (D-Arg-[Hyp3,Igl5,Oic7,Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3,Igl5,D-Igl7,Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation. Bawolak MT; Gera L; Morissette G; Stewart JM; Marceau F J Pharmacol Exp Ther; 2007 Nov; 323(2):534-46. PubMed ID: 17699739 [TBL] [Abstract][Full Text] [Related]
7. The kinin B1 receptor antagonist des-Arg9-[Leu8]bradykinin: an antagonist of the angiotensin AT1 receptor which also binds to the AT2 receptor. Pruneau D; Duvoid A; Luccarini JM; Bélichard P; Bonnafous JC Br J Pharmacol; 1995 Jan; 114(1):115-8. PubMed ID: 7712006 [TBL] [Abstract][Full Text] [Related]
8. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis. Butt SK; Dawson LG; Hall JM Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687 [TBL] [Abstract][Full Text] [Related]
9. Development and in vivo evaluation of metabolically resistant antagonists of B1 receptors for kinins. Drapeau G; Audet R; Levesque L; Godin D; Marceau F J Pharmacol Exp Ther; 1993 Jul; 266(1):192-9. PubMed ID: 8392550 [TBL] [Abstract][Full Text] [Related]
11. Synergism between the contractile effect of epidermal growth factor and that of des-Arg9-bradykinin or of alpha-thrombin in rabbit aortic rings. deBlois D; Drapeau G; Petitclerc E; Marceau F Br J Pharmacol; 1992 Apr; 105(4):959-67. PubMed ID: 1504721 [TBL] [Abstract][Full Text] [Related]
12. Absence of ligand-induced regulation of kinin receptor expression in the rabbit. Sabourin T; Guay K; Houle S; Bouthillier J; Bachvarov DR; Adam A; Marceau F Br J Pharmacol; 2001 Aug; 133(7):1154-62. PubMed ID: 11487527 [TBL] [Abstract][Full Text] [Related]
13. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor. Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513 [TBL] [Abstract][Full Text] [Related]
14. Vascular kinin B(1) and B(2) receptor-mediated effects in the rat isolated perfused kidney - differential regulations. Bagaté K; Develioglu L; Imbs JL; Michel B; Helwig JJ; Barthelmebs M Br J Pharmacol; 1999 Dec; 128(8):1643-50. PubMed ID: 10588918 [TBL] [Abstract][Full Text] [Related]
15. Fluorescent ligands of the bradykinin B1 receptors: pharmacologic characterization and application to the study of agonist-induced receptor translocation and cell surface receptor expression. Bawolak MT; Gera L; Morissette G; Bouthillier J; Stewart JM; Gobeil LA; Lodge R; Adam A; Marceau F J Pharmacol Exp Ther; 2009 Apr; 329(1):159-68. PubMed ID: 19136639 [TBL] [Abstract][Full Text] [Related]
16. Functional characterization of bradykinin analogues on recombinant human bradykinin B(1) and B(2) receptors. Simpson PB; Woollacott AJ; Hill RG; Seabrook GR Eur J Pharmacol; 2000 Mar; 392(1-2):1-9. PubMed ID: 10748265 [TBL] [Abstract][Full Text] [Related]
17. Correlation between brain bradykinin receptor binding sites and cardiovascular function in young and adult spontaneously hypertensive rats. Cloutier F; Ongali B; Campos MM; Thibault G; Neugebauer W; Couture R Br J Pharmacol; 2004 May; 142(2):285-96. PubMed ID: 15066903 [TBL] [Abstract][Full Text] [Related]
18. Pulse exposure to protein synthesis inhibitors enhances vascular responses to des-Arg9-bradykinin: possible role of interleukin-1. deBlois D; Bouthillier J; Marceau F Br J Pharmacol; 1991 May; 103(1):1057-66. PubMed ID: 1878745 [TBL] [Abstract][Full Text] [Related]
19. B1 and B2 kinin receptors on cultured rabbit superior mesenteric artery smooth muscle cells: receptor-specific stimulation of inositol phosphate formation and arachidonic acid release by des-Arg9-bradykinin and bradykinin. Tropea MM; Gummelt D; Herzig MS; Leeb-Lundberg LM J Pharmacol Exp Ther; 1993 Feb; 264(2):930-7. PubMed ID: 8382284 [TBL] [Abstract][Full Text] [Related]
20. Mechanisms involved in the contractile responses of kinins in rat portal vein rings: mediation by B1 and B2 receptors. Campos AH; Calixto JB J Pharmacol Exp Ther; 1994 Feb; 268(2):902-9. PubMed ID: 8114004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]